GBA's "2021 Stock Phantasma"

Foot Locker price target raised to $82 from $80 at Cowen 08:19 FL Cowen analyst John Kernan raised the firm's price target on Foot Locker to $82 from $80 and keeps an Outperform rating on the shares. The analyst said guidance can prove conservative for 2H and he acknowledges a tough Q3 comparison but with an opportunity for a significant acceleration into Q4 on an easier comparison.

Watch For This-> News came out monday...
Skillz files to sell 4.4M shares for selling stockholders
 
Poor Clive. He was the guy behind the NYC concert that flopped so bad when the rains came.

I'm hoping for some ping action on MQ.. because they work with AFRM...

Truist starts Marqeta at Buy on next-gen vCard solutions success 08/18 MQ, SQ, DASH, AFRM As previously reported, Truist analyst Andrew Jeffrey initiated coverage of Marqeta (MQ) with a Buy rating and $37 price target. The analyst is positive on the company's next-gen vCard solutions, which offer faster and more flexible issuing and processing to emerging growth names like Square (SQ), DoorDash (DASH) and Affirm (AFRM). Jeffrey adds that while the company has found initial success with emerging growth customers, its long-term value creation will accompany penetration of legacy issuers in the $3T U.S. debit and prepaid issuing market.
 
stonedinvestor said:
Poor Clive. He was the guy behind the NYC concert that flopped so bad when the rains came.
More...
Uhhhh---- Stoney.
That sentence reads like you're referring to someone that tried something and failed. Poor Clive?!
I'd hardly describe this as a "flop" Stoney.

++++++++++++++++++++++++++++++++++++++++++++++++
https://www.rollingstone.com/music/...gsteen-paul-simon-patti-smith-polo-g-1214217/

"Yes, it rained. And rained and rained. But not for the first two hours. For the first two hours, Clive Davis’s Central Park concert was a masterpiece. And then the weather intervened.

But wait: before the rain, the concert was glorious. Everything with the New York Philharmonic, especially Jennifer Hudson tackling “Nessun Dorma” as a tribute to Aretha, she deserves the highest praise.

Rob Thomas and Santana performing “Smooth,” the “Layla” of its generation. Rob glowing from sweat, coming off the humid stage after his mic mix was a mess — the perils of live performance. But “Smooth” really solidified the audience. Even Maluma’s posse was dancing to it in the family section just below the stage.

And there was nothing like seeing 60,000 people sing along to “September” with Earth Wind & Fire, Philip Bailey had them in the palm of his hand. Verdine White, in his bejeweled jacket, rocking those guitar solos, brother Maurice smiling down from heaven. Pure pleasure."
+++++++++++++++++++++++

Nor would I ascribe the adjective "poor" to a Brooklyn born orphan who made it to Harvard Law, went into the music biz, and proceeded to sign Billy Joel, Janis Joplin, Pink Floyd, Springsteen, Whitney, Barry Manilow, Aerosmith, Simon and Garfunkle... and pretty much any other damn act he chooses.

Yeah... poor Clive.
Lets see you pull that off at age 89. :cool:
 
Ha! Poor as in poor luck-- Or Pour luck... He had Bruce to close but mother nature spoke loudest. The concert was supposed to be heavily programmed to give the illusion that NYC was back, a lot of false propaganda went unsaid-- in that sense it was a total bust.

Are SPAC's making the turn? I don't think so but look at this--> Quietly Back In Charge!

Danimer Scientific (NYSE:DNMR): +33.02%; <-----------
 
stonedinvestor said:
Apparently Opened $33.60 Missed it entirely .... Looked at $33.90 missed it again.... Put an order in at $34.75 but by the time I entered it it was already $35!!!!! Ayyyyyyyy. In $35.70-- He's done it again!

Icosavax, Inc. (ICVX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD

$37.00+2.40 (+6.94%)<----------:thumbsup:
More...

Great close why didn't anybody tell me-!

Icosavax, Inc. (ICVX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD

$39.59+4.14 (+11.68%)<----------:thumbsup:
 
Rover Group, Inc. (ROVR)- Another mild example of SPAC recovery-- pet SPAC went down but came back--
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
$11.27+1.02 (+9.95%)
At close: August 27
 
Stephens starts Zevia at Overweight with $19 price target 08/16 ZVIA As previously reported, Stephens analyst Ben Bienvenu initiated coverage of Zevia with an Overweight rating and $19 price target. He sees Zevia delivering against its opportunity in the liquid refreshments market in the near-term and sees the company having "significant headroom" for store count and retail sales growth over the long-term, Bienvenu tells investors. Zevia has room to get "considerably larger than it is today" within the zero calorie market alone while zero calorie, naturally sweetened beverages are clearly taking share in the broader beverage industry, Bienvenu added.
 
You must log in or register to reply here.
Back
Top